TrialBreast (Edinburgh, Scotland)2020

Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14).

Frédérique Penault-Llorca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.